Results 101 to 110 of about 18,100 (230)
Os autores relatam um caso de ceratodermia palmoplantar hereditária de Unna-Thost, de apresentação clínica atípica, bem como complicação do tipo estrangulamento ainhumóide no quinto dedo de ambos os pés.
Luciana Valentini de Melo Cesarini +5 more
doaj +1 more source
New-Onset Palmar Psoriasis Following mRNA COVID-19 Vaccination: A Case Report
Haya Fahad A Alzamami,1 Omer A AlSulaiman,1 Gaeda Khaled I Alkaltham,2 Hadeel K Alotaibi3 1Department of Dermatology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia; 2Department of Dermatology, Ministry of Health ...
Alzamami HFA +3 more
doaj
Palmoplantar hyperkeratotic projections [PDF]
Wendi Bao, BS +2 more
openaire +3 more sources
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core
Could the IL‐17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 728-729, May 2026.
Ulrich Mrowietz, Sascha Gerdes
wiley +1 more source
Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein‐1 mutation: A case report
Key Clinical Message Keratosis palmoplantaris striata type I (SPPK‐I) is a rare autosomal‐dominant type of hereditary epidermolytic palmoplantar keratoderma, which can be caused by mutations in desmoglein‐1 (DSG‐1).
Kevin Koschitzki +8 more
doaj +1 more source
Safety of guselkumab in hepatitis B virus infection [PDF]
Reactivation of hepatitis B virus (HBV) following the use of TNF antagonists has been reported and is a contraindication to use of these medications. Although the risk of reactivation of HBV during use of ustekinumab and secukinumab is low in patients ...
Duncan, James Robert +2 more
core
Ustekinumab Efficacy in Children with Palmoplantar Psoriasis: Case Series
Background. Management with genetically engineered biologic drugs is recommended for patients with palmoplantar psoriasis when standard external therapy, physical therapy, and classical immunosuppressants lack efficacy.
Maria A. Leonova +7 more
doaj +1 more source

